Invariant T Cell Immunology and Function

Invariant T cells constitute a specialised branch of the adaptive immune system that bridge innate and adaptive responses through semi‐invariant antigen recognition. Two principal subsets, mucosal-associated invariant T (MAIT) cells and invariant natural killer T (iNKT) cells, express conserved T cell receptors (TCRs) that detect non‐peptide antigens presented by nonpolymorphic molecules. MAIT cells recognise microbial riboflavin metabolites bound to the MHC class I–related molecule MR1, whereas iNKT cells engage glycolipid antigens displayed by CD1d. Both subsets undergo stepwise thymic selection and peripheral expansion, acquiring tissue-specific phenotypes and effector capabilities. They rapidly produce cytokines and cytotoxic mediators in response to infection, inflammation or tissue damage, exerting roles in antimicrobial defence, tumour surveillance and immune regulation. Their functions are shaped by local microenvironments, cytokine milieus and clonal diversity, with implications for barrier immunity, systemic inflammation and host–microbiome interactions. Advances in single-cell profiling and antigen-presentation biology have delineated the mechanisms governing antigen capture, TCR specificity and functional heterogeneity, highlighting these cells as promising diagnostic biomarkers and therapeutic targets in infectious, inflammatory and malignant diseases.

Research from Nature Portfolio

Recent single-cell transcriptomic and TCR repertoire analyses have revealed that human MAIT cells exhibit considerable phenotypic and clonal diversity across blood and tissue sites. Despite a semi-invariant receptor, individual clones display distinct resting and activation profiles governed by tissue residency and stimulus type, yet all maintain the capacity for rapid cytokine secretion. In parallel, a first-in-human trial of allogeneic iNKT cell therapy demonstrated safety and feasibility in patients with severe acute respiratory distress syndrome. Off-the-shelf iNKT cells homed to inflamed lungs, rescued exhausted lymphocytes and induced a systemic anti-inflammatory cytokine response without dose-limiting toxicity. These findings underscore the therapeutic potential of invariant T cells in modulating hyperinflammation and restoring immune homeostasis in critical illness.

Invariant T Cell Immunology and Function publication trend

The graph below shows the total number of articles in invariant t cell immunology and function across all publications each year (not limited to Nature Index journals).

Technical terms

Invariant T cells: T lymphocytes with semi-invariant TCRs that recognise non-peptide antigens via nonpolymorphic presenting molecules.

Mucosal‐associated invariant T (MAIT) cells: A subset of invariant T cells that detect microbial riboflavin metabolites presented by MR1 and rapidly produce cytokines and cytotoxic mediators.

Invariant natural killer T (iNKT) cells: T cells defined by a conserved TCR that recognises glycolipid antigens bound to CD1d and bridges innate and adaptive immunity.

T cell receptor (TCR): The antigen-recognition molecule on T cells, comprising variable and constant chains that determine specificity.

MR1 and CD1 molecules: Nonpolymorphic antigen‐presentation proteins: MR1 presents small molecule metabolites, CD1 presents lipid antigens to invariant T cells.

References

1. CD1 lipidomes reveal lipid-binding motifs and size-based antigen-display mechanisms. Cell (2023).
2. Single-cell analysis of human MAIT cell transcriptional, functional and clonal diversity. Nature Immunology (2023).
3. A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome. Nature Communications (2024).
4. MAIT cells: new guardians of the liver. Clinical & Translational Immunology (2016).
5. Human Mucosal Associated Invariant T Cells Detect Bacterially Infected Cells. PLOS Biology (2010).
6. Stepwise Development of MAIT Cells in Mouse and Human. PLOS Biology (2009).
7. MAIT Cells Detect and Efficiently Lyse Bacterially-Infected Epithelial Cells. PLOS Pathogens (2013).